Decision of the EEA Joint Committee No 196/2025 of 19 September 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/3]
Date: 2025-09-19
Institutions: EEA Joint Committee
Subjects: European Economic Area, chemical product, endocrine disruptor, iron, market approval, plant health control, plant health product, revision of an agreement, withdrawal from the market




L_202600003EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2026/3


15.1.2026







            DECISION OF THE EEA JOINT COMMITTEE No 196/2025
of 19 September 2025
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/3]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2025/808 of 5 May 2025 amending Implementing Regulation (EU) 2015/408 as regards the deletion of gamma-cyhalothrin, ipconazole and oxamyl from the list of active substances to be considered as candidates for substitution (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2025/833 of 5 May 2025 renewing the approval of the active substance lenacil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulations (EU) No 540/2011 and (EU) 2015/408 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2025/845 of 5 May 2025 approving the active substance elemental iron as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement.












(4)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement is amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32025 R 0833: Commission Implementing Regulation (EU) 2025/833 of 5 May 2025 (OJ L, 2025/833, 6.5.2025),










—



32025 R 0845: Commission Implementing Regulation (EU) 2025/845 of 5 May 2025 (OJ L, 2025/845, 6.5.2025).’














2.


The following indents are added in point 13zzzzt (Commission Implementing Regulation (EU) 2015/408):






‘—



32025 R 0808: Commission Implementing Regulation (EU) 2025/808 of 5 May 2025 (OJ L, 2025/808, 6.5.2025),










—



32025 R 0833: Commission Implementing Regulation (EU) 2025/833 of 5 May 2025 (OJ L, 2025/833, 6.5.2025).’














3.


The following points are inserted after point 13zzzzzzzzzzzzzzzh (Commission Implementing Regulation (EU) 2025/150):






‘13zzzzzzzzzzzzzzzi.



32025 R 0833: Commission Implementing Regulation (EU) 2025/833 of 5 May 2025 renewing the approval of the active substance lenacil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulations (EU) No 540/2011 and (EU) 2015/408 (OJ L, 2025/833, 6.5.2025).










13zzzzzzzzzzzzzzzj.



32025 R 0845: Commission Implementing Regulation (EU) 2025/845 of 5 May 2025 approving the active substance elemental iron as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2025/845, 6.5.2025).’










Article 2
The texts of Implementing Regulations (EU) 2025/808, (EU) 2025/833 and (EU) 2025/845 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 20 September 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 19 September 2025.


For the EEA Joint Committee


The President

Stefán Haukur JÓHANNESSON
            





(1)  
            OJ L, 2025/808, 6.5.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/808/oj.

(2)  
            OJ L, 2025/833, 6.5.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/833/oj.

(3)  
            OJ L, 2025/845, 6.5.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/845/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2026/3/oj
ISSN 1977-0677 (electronic edition)